Please select the option that best describes you:
Do you use amyloid lowering therapy in patients on chronic anticoagulation?
How do you counsel them on the risk?
Answer from: at Academic Institution
I wouldn’t feel comfortable doing this because of the elevated risk of ARIA-H. The Alzheimer’s Association Therapeutics Work Group advised that patients receiving anticoagulants should not be offered lecanemab (Cummings et al., PMID 37357276).
Sign in or Register to read more